CAS: 7291-22-7; Pyridine D5

该化合物是一种环环芳有机化合物,是一种环状环状六人,内含5个碳原子和1个氮原子,其中5个氢原子被氢的稳定的同位素-离子取代;这一替代增强了其在核磁共振光谱学中的效用,因为它提供了一种独特的光谱特征,因为有除化器的存在.Pyridine-d5是一种无色液体,有典型的气味,类似于普通的,并且与水和有机溶剂不相干.它通常用作各种化学反应的溶剂和试剂,特别是在涉及同位素标签的研究中.氮的存在有助于其基本性和再活性,使其在有机合成和分析化学中成为有价值的化合物.在处理这一化合物时,应当注意安全防范,因为它可能有毒,并且对皮肤和呼吸系统产生刺激.

结构式图片

欧盟法规

ECHA物质C&L通报REACH预注册

上下游产品

CAS号110-86-1 吡啶 | CAS号100-70-9 2-氰基吡啶 | CAS号100-54-9 3-氰基吡啶 | CAS号100-48-1 4-氰基吡啶 | CAS号139-66-2 苯硫醚 | CAS号109-99-9 四氢呋喃 | CAS号676-49-3 甲烷-d1 | CAS号1291078-54-0 ethyl (E)-3-(py... | CAS号59607-99-7 (E)-3-(吡啶-3-基)丙烯酸乙酯 | CAS号4423-10-3 吡啶 4-(4-甲基苯基)- | CAS号4467-06-5 2-(对甲苯基)吡啶 | CAS号4423-09-0 3-(4-甲基苯基)吡啶

合成工艺路线路线简述

  • 合成目标产物 Pyridine-D5 主要起始原料 Pyridine
  • (文献来源)合成步骤主要原料 Pyridine
吡啶置于(1,5-Cyclooctadiene)(Methoxy)Iridium(I) Dimer,氘体系中,用 四氢呋喃 作为反应溶剂,55.0 °C,100.0 Kpa 条件下,反应 22.0H,反应生成 氘代吡啶
参考文献:药物的多位点氢同位素标记
标题:药物的多位点氢同位素标记
摘要:摘要放射性标记是药物发现和开发的基础,因为它是临床前 Adme 研究和后期人体临床试验的强制性要求.本文提出了一种通用,有效且易于实施的方法,使用市售且空气稳定的铱预催化剂 [ir(Cod)(Ome)] 来多位点掺入氘和氚原子.2被描述.使用这种方法可以标记大量与药物相关的子结构,包括吡啶,吡嗪,吲哚,咔唑,苯胺,恶唑/噻唑,噻吩以及富电子苯基.各种复杂药物的标记突出了该反应的高官能团耐受性,特别是含有卤素或硫原子和腈基团.多位点氢同位素掺入可以通过原位形成互补的催化活性物质来解释:单金属铱络合物和铱纳米颗粒.
DOI:10.1002/ange.202008519

海关参考信息

专利信息


专利号:US-5856465-A
优先权日:1996-05-24
标 题:Compositions and methods for the synthesis of chirally pure organophosphorus nucleoside derivatives
发明人:STEC WOJCIECH JACEK; WOZNIAK LUCYNA
权利人:POLSKA AKAD NAUK CENTRUM
摘要:Methods for the stereospecific synthesis of chirally pure organophosphorus dinucleotide derivatives and nucleoside monomer synthons used in their synthesis are provided. These methods allow for conversion of nucleoside intermediates of unchosen sense of P-chirality to nucleoside monomer synthons of chosen sense of P-chirality. Also provided are novel nucleoside intermediates useful in such methods.

专利号:US-2006287520-A1
优先权日:2005-05-16
标 题 :Synthesis of salinosporamide A and analogues thereof
发明人:DANISHEFSKY SAMUEL J; ENDO ATSUSHI
权利人:DANISHEFSKY SAMUEL J; ENDO ATSUSHI
摘要:A novel synthesis of salinosporamide A is provided. Salinospoamide A as well as structurally related natural products, omuralide and lactacystin, have been shown to be proteasome inhibitors. Therefore, these compounds as well as analogues of these natural products may be useful in the treatment of proliferative diseases such as cancer, autoimmune diseases, diabetic retinopathy, etc. The invention provides for the synthesis of salinosporamide A as well as analogs thereof using a convenient point for derivatization of the bicyclic core. Pharmaceutical compositions and method of using the inventive compounds are also provided.

专利号:US-5204456-A
优先权日:1986-04-08
标题:Derivatives of nucleosides and their use for the synthesis of oligonucleotides
发明人:MOLKO DIDIER; SCHULHOF JEAN-CLAUDE; TEOULE ROBERT
权利人:COMMISSARIAT ENERGIE ATOMIQUE
摘要:The invention relates to derivatives of nucleosides and their use for the synthesis of oligonucleotides. These derivatives are in accordance with the formula: (I) in which B represents a radical derived from guanine, cytosine or adenine, whose exocylic NH group is protected by the group with R1 representing a hydrogen atom or a alkyl radical and R2 a hydrogen atom, and alkyl radical, an alkoxy radical and optionally substituted aryloxy radical, R3 represents a hydrogen atom, the dimethoxytrityl radical or the radical R4 represents a hydrogen atom, the radical of formula: or a radical suitable for the synthesis of polynucelotides and R5 represents a hydrogen atom or the protected or unprotected hydroxyl OH radical.

专利号:EP-0850248-B1
优先权日:1995-09-01
标 题 :Compositions and methods for the synthesis of organophosphorus derivatives
发明人:STEC WOJCIECH J; WOZNIAK LUCYNA
权利人:POLSKA AKAD NAUK CENTRUM
摘要:Methods for the stereospecific synthesis of chirally pure organophosphorus dinucleotide derivatives and nucleoside monomer synthons used in their synthesis are provided. These methods allow for conversion of nucleoside intermediates of unchosen sense of P-chirality to nucleoside monomer synthons of chosen sense of P-chirality. Also provided are novel nucleoside intermediates useful in such methods.

专利号:US-6262251-B1
优先权日:1995-10-19
标题 :Method for solution phase synthesis of oligonucleotides
发明人:PIEKEN WOLFGANG; MCGEE DANNY; SETTLE ALECIA; ZHAI YANSHENG; HUANG JIANPING
权利人:PROLIGO LLC
摘要:This invention discloses an improved method for the sequential solution phase synthesis of oligonucleotides. The method lends itself to automation and is ideally suited for large scale manufacture of oligonucleotides with high efficiency.

专利号:WO-9847910-A1
优先权日:1997-04-21
标题:Method for solution phase synthesis of oligonucleotides
发明人:PIEKEN WOLFGANG; MCGEE DANNY; SETTLE ALECIA; ZHAI YANSHENG; HUANG JIANPING; HILL KEN; SMITH RANDALL S
权利人:NEXSTAR PHARMACEUTICALS INC; PIEKEN WOLFGANG; MCGEE DANNY; SETTLE ALECIA; ZHAI YANSHENG; HUANG JIANPING; HILL KEN; SMITH RANDALL S
摘要:This invention discloses an improved method for the sequential solution phase synthesis of oligonucleotides. The method lends itself to automation and is ideally suited for large scale manufacture oligonucleotides with high efficiency.
北京崇熙科技孵化器有限公司
⚠️ 未注册 · 未认证企业
⚠️ 该商家尚未完成注册及企业认证,请用户仔细辨别,谨慎交易。
数据来源于公开网络搜索,平台未作核实,请自行辨别。
🏢敬请 企业认领
🏬开设公司展台
📢获取免费会员权益
🎖️点亮专属注册企业标签
📇展现公司完整信息 样本查看立即注册认领 →
网址: http://www.chongxichem.com
企业联系电话:010-67334451👤
📞北京崇熙科技孵化器有限公司 ⚠️参考联系方式
联系人:刘经理
电话:010-67334451

传真:010-8150-2846
邮箱:info@chongxichem.com
通信地址: 北京市朝阳区大羊坊路79号旌凯大厦216室
邮编: 100021
🆔 联系时候可告知是从"百琢研"平台获取的信息.
⚠️ 声明: 该企业未认证、未认领,请自行辨别信息的真实性和可靠性。咨询或交易时请注意风险评估与信息核实,百琢研不参与任何交易。企业认领注册入口→

地址:北京市朝阳区大羊坊路79号旌凯大厦216室
⚠️ 未注册 · 未认证企业
注册入口 备注: 📌 数据来源说明:本展台内容基于各搜索引擎等公开数据整理,仅作展示用途。请用户自行辨别
✉️ 若企业需抹除展台内容或有异议, 请通过页面底部联系方式告知我们,我们会尽快处理。
上海亚兴生物医药科技有限公司
⚠️ 未注册 · 未认证企业
⚠️ 该商家尚未完成注册及企业认证,请用户仔细辨别,谨慎交易。
数据来源于公开网络搜索,平台未作核实,请自行辨别。
🏢敬请 企业认领
🏬开设公司展台
📢获取免费会员权益
🎖️点亮专属注册企业标签
📇展现公司完整信息 样本查看立即注册认领 →
网址: http://www.isotopemall.com
企业联系电话:021-58956006,021-58950017👤
📞上海亚兴生物医药科技有限公司 ⚠️参考联系方式
联系人:段经理
电话:021-58956006,021-58950017
手机:15800617331
传真:021-58956100
邮箱:sales@langchem.com
通信地址: 上海川沙新镇妙镜路1111弄恒越生活广场5号楼303室
邮编: 201204
🆔 联系时候可告知是从"百琢研"平台获取的信息.
⚠️ 声明: 该企业未认证、未认领,请自行辨别信息的真实性和可靠性。咨询或交易时请注意风险评估与信息核实,百琢研不参与任何交易。企业认领注册入口→

地址:上海川沙新镇妙镜路1111弄恒越生活广场5号楼303室
⚠️ 未注册 · 未认证企业
注册入口 备注: 📌 数据来源说明:本展台内容基于各搜索引擎等公开数据整理,仅作展示用途。请用户自行辨别
✉️ 若企业需抹除展台内容或有异议, 请通过页面底部联系方式告知我们,我们会尽快处理。
第 1 / 1 页

供应商参考报价(招募中)

品牌试剂参考报价(招募中)

📌 第三方产品分析报告

✅ COA系统入驻 | 共享模式

主要参考文献

参考标题:Sequential 1,3-N- To C- And 1,3-C- To C-Migration Of Sulfonyl Groups Through The Synthesis Of 1,4-Diazepines From The Aza-[5 + 2] Cycloaddition Of Indoloazomethine Ylides
作者:Namrim Heo,Ilyong Jung,Dae Kyum Kim,Sang Hoon Han,Kooyeon Lee,Phil Ho Lee |发布日期:2020.8.21
摘要:Sequential 1,3-N- To C- And 1,3-C- To C-Migration Of Sulfonyl Groups Through The Synthesis Of 1,4-Diazepines From An Operationally Simple Thermal Aza-[5 + 2] Cycloaddition Reaction Of Indoloazomethine Ylides With Dialkyl Acetylenedicarboxylates Under Mild Conditions, Leading To The Formation Of C-Sulfonylated 1,4-Diazepines.

合成参考文献


参考文献:10.1007/978-1-61779-188-8_3
摘要:Hari Y, Kodama T, Imanishi T, Obika S. 2'-O,4'-C-methyleneoxymethylene bridged nucleic acids (2',4'-BNA(COC)). Methods Mol Biol. 2011;764():31–57. doi: 10.1007/978-1-61779-188-8_3.
📝 需求与反馈
尽可能描述清楚需求与问题信息
×

通知